CombiMatrix Posts Decline in Q2 Revenues; Seeking Options for Business | GenomeWeb

NEW YORK (GenomeWeb News) – CombiMatrix reported after the close of the market Wednesday that its second-quarter revenues declined around 43 percent, which the firm said was due to "non-recurring events."

The Mukilteo, Wash.-based life science tools and molecular diagnostics firm also said that it is seeking options for the company, including a potential acquisition or partnership.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: a sequencing-based screen of Lyme disease-causing pathogen, the range of animals bitten by Anopheles darling mosquitoes in Peru, and more.

An NC State researcher is exploring the use of CRISPR-Cas3 as an anti-microbial, Gizmodo reports.

The Earth BioGenome Project plans to sequence all life on Earth, according to ScienceInsider.

For those who are concerned about Trump administration actions related to science, a new column in Scientific American has suggestions for ways to fight back.